Our research is highly collaborative and explores the role of the microbiome in several globally significant diseases. Our researchers combine their clinical and basic science expertise to answer pertinent questions and uncover the full potential of the microbiome in view of delivering novel patient-centric therapies and reducing the overall burden of disease.
We are studying several diseases that fall under the following five themes: cancer, women and children’s health, infection, immunity and inflammation, critical care and mental health and neuroscience.
We are particularly interested in gastrointestinal cancers including gastric, oesophageal and colorectal, liver cancer and skin cancer. We are also studying the role of the microbiome in inflammatory bowel disease, Helicobacter pylori infection and its associated diseases, fatty liver disease, Alzheimer’s disease, pregnancy and pregnancy-related diseases, urogynecological diseases, thrombosis, schizophrenia and various autoimmune diseases.